Stammdaten
Unternehmen
| Name | Crinetics Pharmaceuticals, Inc. |
|---|---|
| Ticker | CRNX |
| CIK | 0001658247 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Titel | Crinetics Pharmaceuticals, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:34:52.085605 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | Vivaldi Coelho Rogerio | Director | Open Market Sale | -523 | 36.77 | -19,230.71 | -5,8% | |
| 2026-03-12 | Vivaldi Coelho Rogerio | Director | Open Market Sale | -4,477 | 36.08 | -161,530.16 | -48,4% | |
| 2026-03-03 | Schilke Tobin | Officer, Chief Financial Officer | Open Market Sale | -6,713 | 39.67 | -266,304.71 | -79,9% | |
| 2026-01-05 | Kalofonos Isabel | Officer, Chief Commercial Officer | Open Market Sale | -2,500 | 55.00 | -137,500.00 | -41,2% | |
| 2025-10-01 | Pizzuti Dana | Officer, Chief Med and Dev Officer | Open Market Sale | -5,000 | 41.81 | -209,050.00 | -62,7% | |
| 2025-09-26 | Fust Matthew K | Director | Open Market Sale | -16,000 | 44.75 | -716,000.00 | -214,7% | |
| 2025-09-26 | Fust Matthew K | Director | Open Market Sale | -16,000 | 44.75 | -716,000.00 | -214,7% | |
| 2025-09-26 | Struthers Richard Scott | Director, Officer, President & CEO | Open Market Sale | -4,000 | 45.00 | -180,000.00 | -54,0% | |
| 2025-09-02 | Pizzuti Dana | Officer, Chief Med and Dev Officer | Open Market Sale | -5,000 | 32.10 | -160,500.00 | -48,1% | |
| 2025-08-22 | Pizzuti Dana | Officer, Chief Med and Dev Officer | Open Market Sale | -30,000 | 30.43 | -912,900.00 | -273,7% | |
| 2025-08-20 | Pizzuti Dana | Officer, Chief Med and Dev Officer | Open Market Sale | -6,492 | 29.18 | -189,436.56 | -56,8% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.